Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: August 2011

2 - Colloid fluids

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Clinical Fluid Therapy in the Perioperative Setting
  • Online ISBN: 9780511733253
Please enter your name
Please enter a valid email address
Who would you like to send this to *


1. HedinA, HahnRG. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci 2005; 106: 217–24.
2. MarikPE. The treatment of hypoalbuminemia in the critically ill patient. Heart Lung 1993; 22: 166–70.
3. GuthrieRD, HinesC. Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 1991; 86: 255–63.
4. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised trials. BMJ 1998; 317: 235–40.
5. RobertsI, EdwardsP, McLellandB. More on albumin. Use of human albumin in UK fell substantially when systematic review was published (letter). BMJ 1999; 318: 1214–15.
6. WilkesMM, NavickisRJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135: 149–64.
7. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New Engl J Med 2004; 350: 2247–56.
8. The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New Engl J Med 2007; 357: 874–84.
9. SvensénC, HahnRG. Volume kinetics of Ringer solution, dextran 70 and hypertonic saline in male volunteers. Anesthesiology 1997; 87: 204–12.
10. HahnRG. Dextran 70 and the blood loss during transurethral resection of the prostate. Acta Anaesthesiol Scand 1996; 40: 820–4.
11. DrobinD, HahnRG. Kinetics of isotonic and hypertonic plasma volume expanders. Anesthesiology 2002; 96: 1371–80.
12. ChristensenP, AnderssonJ, RasmussenSE, AndersenPK, HennebergSW. Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients. Acta Anaesthesiol Scand 2001; 45: 414–20.
13. LehmannGB, AsskaliF, BollM, et al. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007; 98: 635–44.
14.Voluven 6% hydroxyethyl starch 130/0.4 product monograph. Bad Homburg (Germany), Fresenius Kabi, 2007.
15. IckxBE, BepperlingF, MelotC, SchulmanC, van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003; 91: 196–202
16. SchortgenF, LacheradeLC, BruneelF, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911–16.
17. BrunkhorstFM, EngelC, BloosF, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125–38.
18. BéchirM, PuhanMA, NeffSB, et al. Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury. Crit Care 2010; 14: R123.
19. LaxenaireMC, CharpentierC, FeldmanL. Anaphylactoid reactions to colloid plasma substitutes: incidence risk factor mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanimat 1994; 13: 301–10.
20. HahnRG. Volume kinetics of infusion fluids (review). Anesthesiology 2010; 113: 470–81.
21. VelanovichV. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105: 65–71.
22. SchierhoutG, RobertsI. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316: 961–4.
23. ChoiPT, YipG, QuinonezLG, CookDJ. Crystalloids vs. colloids in fluid resuscitation: a systemtic review. Crit Care Med 1999; 27: 200–10.